You are here

Grace Bio-oncology Laboratoryo

Company Information
Address
900 Auburn Road, Suite 105
Pontiac, MI 48342
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: Yes



Award Charts




Award Listing

  1. Perfusion Devices for Cell Analysis

    Amount: $750,000.00

    The plan is to test the hypothesis that sufficient porosity can be created in thin tissue sectionsto move reactants dynamic perfusion. This is expected to require control of the freezing rate inlyophi ...

    SBIRPhase II1996Department of Health and Human Services
  2. Specimen Preparation for In Situ PCR

    Amount: $75,000.00

    Our objective is to increase the sensitivity of in situ PCR , by improving methods of specimenpreparation. We have devised a LYOPHILM technology, which comprises lyophilization of specimen onspecializ ...

    SBIRPhase I1994Department of Health and Human Services
  3. Perfusion Devices for Cell Analysis

    Amount: $75,000.00

    N/A

    SBIRPhase I1994Department of Health and Human Services
  4. Method to Preserve Labile Cytochemical Targets

    Amount: $50,000.00

    We will develop a new technology to address the need for a routine clinical method to preserve tissue for cytochemical assay. The new technology addresses the fact that frozen specimens are preferred ...

    SBIRPhase I1993Department of Health and Human Services
  5. A PROBE-CLIP DEVICE FOR IN SITU ASSAY OF BIOLOGICAL MOLECULES

    Amount: $479,611.00

    THE OBJECTIVE IS TO DEVELOP NEW IN SITU (HYBRIDIZATION AND IMMUNOCYTOCHEMISTRY) ASSAY TECHNOLOGY TO TAKE FULL ADVANTAGEOF THE NEW GENERATION OF REAGENTS FOR DETECTING LOW-ABUNDANCE REGULATORY MACROMOL ...

    SBIRPhase II1992Department of Health and Human Services
  6. FREEZE-TRANSFER METHOD FOR IN SITU DETECTION OF RNA

    Amount: $485,032.00

    THE OBJECTIVE IS TO DEVELOP A RAPID AND SENSITIVE ASSAY FOR IN SITU DETECTION OF RECEPTOR AND RELATED C-ONC MRNA IN BREAST CANCER. IN SITU IS THE METHOD OF CHOICE BECAUSE MODEST CHANGES IN PER CELL CO ...

    SBIRPhase II1991Department of Health and Human Services
  7. A PROBE-CLIP DEVICE FOR IN SITU ASSAY OF BIOLOGICAL MOLECULES

    Amount: $50,000.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  8. FREEZE-TRANSFER METHOD FOR IN SITU DETECTION OF RNA

    Amount: $49,999.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  9. ONCOGENE MARKERS AND CANCER RISK IN BENIGN BREAST CANCER

    Amount: $50,000.00

    THIS RESEARCH WILL DEVELOP AN ASSAY TO PREDICT WHICH PATIENTS ARE AT HIGH RISK TO DEVELOP INVASIVE CANCER AT THE TIME OF BIOPSY-PROVEN BENIGN BREAST DISEASE. THE APPROACH WILL QUANTITATE CELLS IN BENI ...

    SBIRPhase I1989Department of Health and Human Services
US Flag An Official Website of the United States Government